News

Using an infrared sensor, biophysicists have succeeded in analysing quickly and easily which active agents affect the structure of proteins and how long that effect lasts.

Brain imaging studies showed that the drug impairs function in key brain regions involved in learning and memory.

Researchers have reported the results of the first randomised clinical trial to test a novel strategy involving waking up and then killing the 'sleeping' HIV that is hiding in the body using an experimental approach known as 'kick and kill'.

Interdisciplinary efforts describe cell packing in convex enclosures using mathematical modeling and direct observations

A signaling pathway that helps promote normal cell growth worsens a form of leukemia by taking control of another pathway better known for protecting cells from biological stress, a new study shows.

Researchers have accidentally discovered that a known enzyme plays a role in allergies and asthma. It could be a target for active pharmaceutical ingredients.

Company to address unmet medical needs in the field of rare metabolic disorders.

Like driving at night and being able to read the license plate of an oncoming car without being blinded by the lights.

Two grants worth more than $2.2 million have been to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.

University of Wisconsin–Madison Professor of Chemistry Shannon Stahl has received the Steenbock Professorship in Chemical Sciences. In addition to advancing the fundamental science in this area, Stahl has been involved in numerous industrial collaborations that have led to practical applications, including target applications relevant to pharmaceutical synthesis.